A bdominal aortic aneurysm (AAA) is characterized by extensive remodeling of the aortic wall, which results in a weakened and dilated aorta that is prone to rupture. [1] [2] [3] [4] The incidence of AAA is associated with the clinical risk factors of smoking, hypercholesterolemia, and hypertension, and it affects ≈8% of men aged >65 years. 1 Rupture of an AAA carries a risk of death up to 90% and is among the leading causes of death in the United States. 5 Currently, there are no available nonsurgical therapies to treat AAA. 6, 7 A hallmark of AAA in both diseased humans and animal models is the presence of extensive inflammatory macrophages and lymphocytes by histological examination. 8 These infiltrating cells exacerbate tissue injury by releasing cytokines, chemokines, and adhesion molecules. 9, 10 Human aneurysmal aortas, along with mouse models of AAA, demonstrate upregulation of interleukin-6 and monocyte chemotactic protein 1 (MCP1) in the aortic wall. 8, 11, 12 Inflammatory macrophages cause activation of matrix metalloproteinases, resulting in both the degradation of collagen and its associated collagenous matrix, along with elastin fragmentation and smooth muscle cell apoptosis. 13 These pathways act in synergy to progressively weaken the aortic wall, predisposing it to rupture. 2, 3, 14 The Notch signaling pathway is important in a wide spectrum of developmental processes, but recently it has been implicated in the molecular pathogenesis of cancer and cardiovascular disease. 15, 16 The Notch signaling pathway consists of a family of 4 Notch receptors (1) (2) (3) (4) that interact with the Jagged and Delta family of ligands. In the canonical signaling pathway, Notch1 is activated after receptor-ligand binding at the cell surface, resulting in the release and translocation of the Notch1 intracellular domain (NICD) to the nucleus where it functions as a transcriptional activator. 17 Mice lacking Notch1 display experience embryonic lethality with profound cardiovascular defects, whereas heterozygous deletion of Notch1 is associated with mild aortic valve calcification. 18, 19 Notch1 signaling has also been shown to be critical for the development and activation of lymphocytes and macrophages in various cell culture studies. 15, 20, 21 The role of Notch1 signaling in inflammatory aneurysmal disease, however, has not been addressed.
To obtain insight into the role of Notch1 signaling in aortic aneurysm development, we generated Notch1 +/− ; Apoe −/− mice and conducted our studies in the angiotensin II (AngII)-induced mouse model of AAA. Although AngII infusion studies have reported differences compared with AAA pathophysiology in human patients, it resembles the human AAA in male propensity, localized dilation of aorta, and histological features of the aortic injury and is a commonly used model. 22 Here, we show that the Notch1 signaling pathway is activated in the aneurysmal aorta of the AngII-treated Apoe −/− mice and that haploinsufficiency or pharmacological inhibition of Notch1 significantly reduces the incidence of AAA by a macrophage-mediated mechanism.
Materials and Methods
A detailed description of the Methods is available in the online-only Data Supplement.
Generation of Notch1 +/− ;Apoe −/− Mice
Apoe −/− and Notch1 +/− ;Apoe −/− littermates were generated as described in the Methods in the online-only Data Supplement. Animal experiments were approved by Institutional Animal Care and Use Committee at the Research Institute at Nationwide Children's Hospital.
Human Aortic Tissue Samples
Tissue specimens were collected from the infrarenal abdominal aorta of patients undergoing AAA repair (n=3). Nonaneurysmal infrarenal aortic tissue samples (n=3) were collected at the time of autopsy of individuals with no evidence of AAA. The collection of the human tissues was approved by the Institutional Review Board of Wayne State University, Detroit, MI.
AngII Infusion and DAPT Treatment
Mini-osmotic pumps containing AngII (1000 ng/min per kg) or saline were implanted subcutaneously in anesthetized male mice (8-10 weeks old) following the standard protocol. A group of Apoe −/− mice (n=10) were injected with a Notch inhibitor, N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT). 23, 24 
Transabdominal Ultrasound Imaging
For in vivo imaging of the abdominal aorta, 2-dimensional (B-mode) transabdominal ultrasound images were obtained at weekly intervals after the implantation of osmotic pumps using a VisualSonics Vevo2100 imaging system (Ontario, Canada) with a mechanical transducer (MS400).
Histology and Immunostaining
Experimental animals were euthanized and the aortas were dissected, fixed in 10% formalin, and maximum aortic diameters measured. Serial sections were stained with hematoxylin and eosin, elastin, and immunohistochemistry (IHC) with antibodies to NICD, mouse monocyte-macrophage marker (MOMA2), and MCP1, as described. 25, 26 Specificity of NICD, MOMA2, and MCP1 staining was determined using nonspecific IgG against the source of host species.
Bone Marrow Transplantation Studies and Quantification of Leukocytes
Recipient mice were irradiated with single dose of 1000 rad from a cesium source. Bone marrow-derived cells were obtained from the tibia and femur of donor mice and were injected into the tail vein of 7-to 8-week-old irradiated recipient mice (1 × 10 7 cells/mL).
Cell Isolation and Flow Cytometry
After 7 days of AngII infusion, macrophages were isolated from the abdominal aorta, and lymphocytes were isolated from the abdominal aorta, spleen, and peripheral blood. Cells were sorted with fluorescence-activated cell sorting after staining with macrophage (Cd11b and Cd14) or lymphocyte markers (Cd3, Cd4, Cd8).
Macrophage Migration and Proliferation Studies
Mice were injected intraperitoneally with sterile thioglycollate broth to elicit in vivo macrophage proliferation. For the scratch assay, cells were grown as a monolayer and then scraped to create an injury. To assess proliferation, immunostaining was performed on these fixed cells with Ki67. For chemotactic-induced migration, cells were grown in 8 µmol/L polycarbonate filter transwell membrane plates (upper chamber), and lower chamber media was supplemented with 100 nmol/L n-formyl-met-leu-phe. 27, 28 Bone marrow-derived macrophages (BMDM) were isolated from femurs and tibias of Apoe −/− and Notch1 +/− ;Apoe −/− mice. BMDM were stimulated for 24 hours with 100 ng/mL lipopolysaccharide (LPS) and interferon-γ (20 ng/mL) for M1 polarization or IL-4 (20 ng/mL) for M2 polarization.
RNA Isolation and Quantitative Reverse Transcriptase Polymerase Chain Reaction
The suprarenal aorta of ≈5 mm in length was frozen in RNA-later reagent, and mRNA was extracted using TRIzol reagent after homogenizing tissue with TissueLyser II. Macrophages were washed and RNA extracted using RNeasy kit (Qiagen). cDNA was synthesized and subjected to real-time quantitative reverse transcriptase polymerase chain reaction.
Statistical Analysis
Statistical comparisons were performed using either Student t test or 1-way ANOVA followed by the Bonferroni multiple comparison test. GraphPad PRISM V5.0 (San Diego, CA) was used for these comparisons, and P<0.05 was considered significant. For the statistical analysis of actual incidence, the Fisher exact test was performed using the SAS software (Cary, NC). To analyze the bone marrow transplantation (BMT) data for the 2-group comparisons at each time point, 2-sample t or Wilcoxon sum rank test and log rank test were used depending on the data distribution.
Results

Notch1 Is Activated in Response to AngII in Apoe −/− Mice
To determine whether Notch1 signaling is altered in the formation and progression of AAA, we examined the expression of NICD, the active form of Notch1, in the abdominal aorta of AngII-induced mouse model of AAA. NICD immunoreactivity was increased in the aneurysmal aorta of AngIItreated Apoe −/− mice compared with Apoe −/− mice treated with saline at day 7 ( Figure 1A -1F) and day 28 ( Figure 1G -1L). At day 7, increased NICD signaling was restricted to the vicinity of vascular injury and was localized with inflammatory macrophages as determined by double immunofluorescence using the monocyte and macrophage marker (MOMA2; Figure 
Notch1 Haploinsufficiency Reduces the Occurrence of AAA in AngII-Induced Mouse Model
Next, we examined whether Notch1 haploinsufficiency affects the incidence of AAA in the AngII-induced mouse model of AAA. Notch1 +/− , Apoe −/− , and Notch1 +/− ;Apoe −/− mice were treated with AngII or saline for 28 days using published protocols. 2, 14 Transabdominal ultrasound imaging and gross examination at 28 days of AngII demonstrated luminal expansion in the suprarenal region of the abdominal aorta of Apoe −/− mice ( Figure 2E No significant blood pressure differences were observed between Apoe −/− and Notch1 +/− ;Apoe −/− mice with AngII infusion, suggesting that the protective effects of Notch1 haploinsufficiency were not related to blood pressure (data not shown).
Macroscopic measurement of the external diameter of suprarenal aorta demonstrated a significant increase in maximal aortic width of Apoe −/− mice treated with AngII versus saline-treated Apoe −/− mice ( Figure 2M ). In comparison, the maximal aortic width of suprarenal aorta was significantly reduced in the Notch1 +/− ;Apoe −/− mice treated with AngII compared with Apoe −/− mice on similar treatment ( Figure  2M ). In fact, the aortic width of Notch1 +/− ;Apoe −/− mice in response to AngII was not significantly different from Notch1 +/− mice treated with AngII or saline-treated controls ( Figure 2M ). In total, 80% (8/10) of Apoe −/− mice treated with AngII developed AAA, defined as a 50% increase in maximal aortic width, compared with 20% (2/10) of Notch1 +/− ; Apoe −/− mice treated with AngII (P<0.05; Figure 2N ).
Histologically, Apoe −/− mice treated with AngII demon strated cellular and architectural changes of typical AAA, including thrombus formation, adventitial remodeling, inflam matory , which was not surprising as apoptosis of aSMCs is a characteristic feature of AAA. 29 These data demonstrate that Notch1 haploinsufficiency signifi cantly decreased the occurrence of pathological sequela associated with AAA in an established mouse model.
Notch1 Haploinsufficiency in Bone Marrow-Derived Cells Prevents AngII-Induced AAA Formation
The influx of inflammatory cells, consisting of macrophages and lymphocytes, to the site of aneurysm formation is critical for the development of AAA. 2, 30, 31 We performed bone marrow transplantation (BMT) experiments to address the question of whether Notch1 haploinsufficiency in bone marrow-derived cells alters aneurysmal development in Apoe −/− mice ( Figure 3 ; Figure VI in the online-only Data Supplement). After optimizing the irradiation and validating the repopulation procedure, the Apoe −/− (group I, n=12) and Notch1 +/− ;Apoe −/− (group II, n=12) mice were irradiated and reconstituted with bone marrow-derived cells harvested from Notch1 +/− ;Apoe −/− and Apoe −/− mice, respectively. Two additional groups of mice were also studied to serve as control groups: irradiated Apoe −/− mice were repopulated with bone marrow-derived cells harvested from Apoe −/− mice (group III, n=8) and Apoe −/− mice without BMT (group IV, n=6). Transabdominal ultrasound measurements and gross examination demonstrate that infusion of AngII into Apoe −/− mice with Notch1 +/− ;Apoe −/− bone marrow-derived cells (group I) significantly decreased the progression of luminal expansion compared with group II (Figure 3 ; Figure VI in the onlineonly Data Supplement). Notch1 +/− ;Apoe −/− mice repopulated with bone marrow-derived cells from Apoe −/− mice (group II) not only augmented progression of luminal expansion but also increased aortic rupture-associated mortality during 28 days of AngII infusion (P<0.001; Figure 3L ). Consistent with other studies, BMT in irradiated Apoe −/− mice (group III, n=8) led to lower incidence of AngII-induced AAA compared with nonirradiated Apoe −/− mice (group IV; data not shown). 32 Notch1 haploinsufficiency did not affect total leukocyte, monocyte, or lymphocyte count in the peripheral blood (data not shown). Overall, the BMT studies suggest that protective effects of Notch1 haploinsufficiency are preserved after transplantation of bone marrow-derived cells from Notch1 +/− ;Apoe −/− mice into Apoe −/− mice.
Notch1 Haploinsufficiency Reduces Macrophage Infiltration at Site of AAA
Monocyte recruitment and macrophage infiltration occur during early and later stages of AAA development; therefore, we examined the suprarenal abdominal aorta at days 7 and 28 of AngII infusion for the expression of Moma2, a marker of activated macrophages. Similar to AngII exposure for 28 days (Figure 2 ), the aorta of Apoe −/− mice infused with AngII for 7 days showed signs of luminal expansion and elastin degradation, which was absent in Notch1 +/− ;Apoe −/− mice ( Figure Figure 4F, 4H, 4N, and 4P) .
AngII is postulated to play a central role in initiating inflammation in the aorta by increasing the expression of chemokines, adhesion molecules, and cytokines in macrophages. 2, 30, 33 To determine whether Notch1 haploinsufficiency reduces the inflammatory response in the AngII model of AAA, we examined the mRNA expression levels of a panel of cytokines, chemokines, and proinflammatory mediators by quantitative reverse transcriptase polymerase chain reaction in the aortas of Apoe −/− and Notch1 +/− ;Apoe −/− mice treated with AngII for 28 days. Significant reduction of the expression of chemokines and cytokines (Mcp1, Il6, Cxcl10 ) and the proinflammatory mediators (Vegf, iNOS, Icam1, Vcam1) was found in the abdominal aorta of Notch1 +/− ;Apoe −/− mice compared with Apoe −/− mice ( Figure 4Q ).
To determine whether a similar decreased inflammatory response occurs ex vivo, we isolated primary macrophages from the peritoneal cavity of Apoe −/− and Notch1 +/− ;Apoe −/− mice and subjected them to LPS stimulation (100 ng/mL) for 3 hours. LPS, a potent activator of macrophages, is known to upregulate expression of Notch1 and its downstream targets and mimic inflammatory response of AAA in as similar fashion. 15, 34, 35 The expression of Mcp1, Il6, Tnf-α, and iNOS in macrophages from Notch1 +/− ;Apoe −/− mice was ≈60% less than in macrophages from Apoe −/− mice in response to LPS treatment ( Figure 4R ). As expected, the expression of Notch1 was also reduced by ≈60% in the macrophages from Notch1 +/− ;Apoe −/− mice (data not shown). In summary, Notch1 haploinsufficiency decreases macrophage infiltration and resultant inflammatory response, as measured by cytokine and chemokine expression, in response to external stress.
Notch1 Haploinsufficiency Causes Defects in Macrophage Migration and Proliferation by Differentially Regulating M1/M2 Polarization
Given the limitations of IHC in determining the specificity and difficulty in quantification, we assessed direct infiltration of active macrophages and lymphocytes at the site lesion by fluorescence-activated cell sorting analysis. Consistent with our IHC observations, the suprarenal abdominal aorta of Notch1 +/− ;Apoe −/− mice contained a decreased number of inflammatory macrophages with Cd11b and Cd14 staining compared with Apoe −/− mice after 7 days of AngII infusion ( Figure 5A-5C ). Notch1 haploinsufficiency did not alter the differentiation of Cd4 + or Cd8 + lymphocytes at the site of injury, although the total number of Cd3 + T lymphocytes was significantly decreased in the suprarenal aorta of Notch1 +/− ; Apoe −/− mice compared with Apoe −/− mice after 7 days of AngII infusion as determined by fluorescence-activated cell sorting analysis and immunostaining ( Figure IX in the onlineonly Data Supplement). Interestingly, no significant difference was observed in the absolute number of Cd3 + T cells in the spleen ( Figure IX in the online-only Data Supplement) or peripheral blood (data not shown) of these experimental mice.
Because it has been shown that total lymphocyte deficiency had no detectable effect on the development of AAA in the AngII mouse model, 36 we focused on the effects of Notch1 haploinsufficiency on macrophage functions. We first examined whether Notch1 signaling has direct effects on macrophage migration or proliferation. In a classical scratch assay, Notch1 haploinsufficiency significantly decreased the migration of peritoneal-derived primary macrophages toward the injury site after 24 hours ( Figure 5D-5H ). After 24 hours, decreased proliferation was observed in Notch1 +/− ; Apoe −/− macrophages compared with Apoe −/− macrophages as determined by staining with proliferation marker (Ki67; Figure  5I the online-only Data Supplement). To determine whether Notch1 haploinsufficiency affects proliferation of primary macrophages in vivo, thioglycollate injection was used to elicit the recruitment of macrophages to the peritoneal cavity. Notch1 haploinsufficiency resulted in the diminished influx of macrophages by almost 50% at day 4 of the thioglycollate infusion ( Figure XH in the online-only Data Supplement). Recent studies have suggested an integral role for Notch1 to regulate M1 polarization of naive macrophages mediated by synthesis of interferon regulatory factor 8 protein. 37 As expected, expression of interferon regulatory factor 8 was upregulated in the abdominal aorta of Apoe −/− mice in response to AngII at day 7, whereas Notch1 haploinsufficiency prevented upregulation of interferon regulatory factor 8 ( Figure  XI and XJ in the online-only Data Supplement). To determine whether Notch1 regulates polarization of macrophages, we evaluated markers for inflammatory M1-associated genes in response to LPS/interferon-γ stimulation and M2-associated genes in response to IL4 stimulation in the BMDM. Increased expression of Il6, Il12, Tnf-α, and iNOS genes was observed in the BMDM of Apoe −/− mice in response to LPS/interferon-γ, whereas no change was seen with Notch1 haploinsufficiency ( Figure 5N ). More importantly, in response to IL4, the expression of arginase 1 and macrophage galactose N-acetylgalactosamine-specific lectin 2 was higher in BMDM from Notch1 +/− ;Apoe −/− mice compared with Apoe −/− mice, suggesting that Notch1-deficient macrophages are polarized toward the M2 fate ( Figure 5O ). The M1 polarization of macrophages in response to LPS/interferon-γ was further confirmed by fluorescence-activated cell sorting analysis ( Figure XM and XN with increased interferon regulatory factor 8 staining, which was reduced by Notch1 haploinsufficiency (Figure XK and XL in the online-only Data Supplement). Taken together, the results demonstrate that Notch1 haploinsufficiency causes defects in the migration and proliferation functions of macrophages by differentially regulating M1/M2 polarization of macrophages, thus preventing them from infiltrating the site of aneurysm formation in the AngII mouse model.
Pharmacological Inhibition of Notch Signaling Attenuates Aneurysm Development in an AngII-Induced Mouse Model of AAA
Although the BMT studies and flow cytometry data demonstrate a specific role for Notch1 signaling in macrophages, Notch1 is known to be necessary for the proper development of the vasculature. 18 To determine whether the protective effects of Notch1 haploinsufficiency on AAA formation are not secondary to the embryonic functions of Notch1 and to investigate the therapeutic potential of Notch1 inhibition, we examined whether pharmacological inhibition of Notch1 protects against the formation of AAA in adult Apoe −/− mice infused with AngII. Mice were treated with DAPT (10 mg/kg) 3× a week, starting 1 week before initiating the AngII infusion or 3 days after the AngII infusion and continuing for 28 days. 23, 24 These time periods were chosen to determine whether DAPT mimics the effects of Notch1 haploinsufficiency on AAA formation and to determine its therapeutic potential to prevent the progression of AAA after a small aortic dilation is established ( Figure XI in the online-only Data Supplement). Treatment with DAPT resulted in a significant reduction in the aortic diameter and incidence of AAA at both time intervals compared with untreated Apoe −/− mice and was similar to Notch1 +/− ;Apoe −/− mice ( Figure 6A-6D ). Histological analysis of the aorta of the Apoe −/− mice treated with DAPT 7 days before AngII infusion ( Figure 6F and 6I) demonstrated normal aortic wall architecture without infiltration of inflammatory cells compared with untreated mice (Figure 6E and 6H) . Although marginal adventitial thickening was observed in Apoe −/− mice treated with DAPT treatment 3 days after AngII infusion, no visible inflammation was observed ( Figure 6G  and 6J ). Furthermore, pharmacological inhibition of Notch (DAPT) had similar defects in the migration and proliferation of macrophages in a murine macrophage cell line (RAW 264.7 cells; data not shown). DAPT also downregulated the inflammatory response of these macrophages in response to LPS compared with non-DAPT-treated cells (data not shown). Significantly decreased gene expression of Notch1 and its downstream Hey1 expression in the abdominal aorta of these mice were observed with DAPT treatment compared with vehicle-treated Apoe −/− mice ( Figure XIIA -XIIB in the online-only Data Supplement). These studies demonstrate that the reduced incidence of AAA seen with genetic deficiency of Notch1 is not the result of developmental differences in the aortic wall and also demonstrate a potential therapeutic strategy for treatment of AAA.
Discussion
The Notch1 signaling pathway has been implicated in numerous developmental processes and disease states. 15, 16, 18 Here, we provide the first evidence that Notch1 signaling is activated in the abdominal aorta from the AngII-induced mouse model of AAA and in patients with AAA. We also demonstrate that Notch1 haploinsufficiency significantly reduces the incidence of AAA in Apoe −/− mice infused with AngII. The protective effects of Notch1 haploinsufficiency on AAA are mediated by decreased recruitment of inflammatory macrophages at the site of aneurysm. Bone marrow studies demonstrate that Notch1 haploinsufficiency in inflammatory cells is sufficient to reduce the development of AAA. Gene expression studies demonstrate that Notch1 haploinsufficiency results in decreased expression of Il6, Mcp1, and adhesion molecules, which play critical roles in macrophage recruitment at the site of injury in response to stress. Flow cytometry confirmed the selective recruitment of inflammatory macrophages in the suprarenal aorta in response to AngII. Notch1 inhibition reduces M1 polarization of macrophages and promotes their M2 fate, thus causing defects in macrophage migration and proliferation. Consistent with this, pharmacological inhibition of Notch signaling by DAPT attenuated dilation of the abdominal aorta in the AngII-induced model of AAA. These findings suggest that Notch1 actively participates in the process of inflammation by directly regulating cytokines and chemokines critical for macrophage recruitment in the pathogenesis of aneurysm ( Figure XIII in the online-only Data Supplement). Deficiency of Notch1, by preventing this inflammatory cascade, preserves the anti-inflammatory environment and normal aortic wall architecture, thereby attenuating dilation of the suprarenal abdominal aorta.
Although the role of the Notch signaling pathway as a critical regulator of cell fate during development is well established, 16, 38 there is emerging evidence that Notch signaling is also critical in the pathogenesis of a variety of inflammatory diseases. Although NOTCH1 mutations have been associated with bicuspid valve, aortic valve calcification, and thoracic aortic aneurysm, no study has exclusively examined the role of Notch1 in the pathogenesis of AAA. [39] [40] [41] [42] A recent study showed strong correlation of bicuspid valve with thoracic aortic aneurysm, but interestingly none of the patients in their study had AAA, suggesting different pathophysiology for thoracic aortic aneurysm and AAA. 43 There is growing evidence that activation of the Notch1 signaling pathway regulates the expression of an inflammatory cascade that includes Il6 and Mcp1, along with a variety of key inflammatory genes such as iNOS, Cxcl10, Icam1, and Vcam. 15 A recent study suggests that Notch1 signaling alone is sufficient to switch on Il6 mRNA transcription in macrophages. 12 Although deficiency of IL6 and MCP1 has been shown to prevent AAA formation, the role of Cxcl10 receptor in AAA is conflicting. Although increased expression of Cxcl10 is reported in AngII-exposed Apoe −/− mice, deficiency of Cxcl10 has also been shown to augment AAA formation. 44 Overall, our work provides the first evidence suggesting a role for Notch1 signaling in AAA, and further studies are required to decipher the specific role of these inflammatory factors in AAA.
Although remarkable progress has been made in the recent years in understanding the role of Notch1 signaling in the immune system, the complexity of Notch signaling because of its multiple receptors and ligands is not completely understood. Data obtained from our chemotactic studies and immunostaining combined with BMT studies support the hypothesis that Notch1 haploinsufficiency primarily interferes with the migration, proliferation, and activation of macrophages. Consistent with our findings, a recent study reported that myeloid-specific reduction in Notch1 decreases macrophage recruitment and localization during angiogenesis. 45 However, we do not exclude the possibility that Notch1 regulates expression of proinflammatory cytokines in other cells, including aortic SMCs and endothelial cells, in a similar manner as in macrophages. It is worthwhile to mention here that modest levels of Mcp1 expression observed in the intimal endothelial layer and medial smooth muscle layer of the aorta in Notch1 +/− ;Apoe −/− mice seem to be insufficient for the recruitment of macrophages (Figure 4 ; Figure VIII in the online-only Data Supplement). Because monocyte infiltration seems to precede aSMC apoptosis in developing AAA, factors released by monocyte and macrophages may play a primary role in the overall perpetuation of inflammation by regulating the function of aSMCs and endothelial cells in the setting of AAA. 46, 47 Further studies are needed to decipher the crosstalk between macrophages and aSMCs in the setting of AAA.
In our study, Notch1 haploinsufficiency reduced infiltration of Cd3 + T lymphocytes at the site of aneurysm formation. Consistent with other studies, differential effects of Notch1 haploinsufficiency on cytotoxic Cd4 + or Cd8 + T-lymphocyte differentiation in the aneurysmal aorta or spleen were not detectable in response to AngII, suggesting that Notch1 pathway activation is a not a feature of all T cells involved in vascular inflammation and is disease-specific. 21, 48 Furthermore, total lymphocyte deficiency, achieved by developing Apoe −/− mice that lacked the recombination activating gene-1 gene, fails to affect the development of AAA in AngII mouse model, suggesting that lymphocytes are dispensable for AAA. 36 The clinical management of AAA is based on the control of primary risk factors, such as tobacco use, dyslipidemia, hypertension, atherosclerosis, and infection. 6, 7 To prevent the progression or to stimulate the regression of established AAA, there is a critical need to develop pharmacological interventions that can selectively target the features of AAA. Several strategies have been proposed to achieve the objective of impeding AAA progression, but available options fall short of this goal. Our data demonstrate that Notch1 is an important player in the inflammatory process in the setting of AAA and suggest that treatment with Notch1-specific inhibitors may be a potentially promising strategy for slowing aneurysm development. Notch1 inhibitors are potential therapeutic agents for cancer. 49, 50 Based on recent findings that Notch inhibition decreases macrophage infiltration 45 and directly regulates macrophage polarization, 37 it is plausible that targeting Notch1 signaling may hold a promising target-based therapy for developing AAA. Beneficial effects of pharmacological inhibition of γ-secretase have been reported to blunt the inflammatory response in a mouse model of atherosclerosis and reduce plaque formation 51 and also to prevent vascular inflammation in an experimental model of giant cell arthritis. 48 Investigations in other animal models of AAA (elastase and CaCl 2 infusion) will further support the clinical use of Notch1 inhibition as a pharmacological therapy. 11, 14, 52 
